The management of pulmonary tuberculosis in adults notified in Scotland in 1993

Respiratory Medicine

Volumn 92, Issue 11, 1998, Pages 1289-1294

  Simpson, A J ^a,d   Watt, B ^b   Heald, S H ^c   Sudlow, M F ^a   Leitch, A G ^a  

^a NHS LOTHIAN   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c Trinity Park House   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; HUMAN; LUNG TUBERCULOSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM; VARIANCE;

EID: 0031732648     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90230-X     Document Type: Article

References (12)

1. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1990; 45: 403-408.
2. Singapore Tuberculosis Service and British Medical Research Council. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1985; 132: 374-378.
3. Snider DE, Graczyk J, Bek E, Rogowski J. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampicin and pyrazinamide, with and without streptomycin. Am Rev Respir Dis 1984; 130: 1091-1094.
4. Singapore Tuberculosis Service and British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. The results up to 30 months. Tubercle 1981; 62: 95-102.
5. East and Central African and British Medical Research Council. Controlled clinical trial of four short-course regimens of chemotherapy (three six-month and one eight-month) for pulmonary tuberculosis. Tubercle 1983; 64: 153-166.
6. British Thoracic Society. A controlled trial of 6-months chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984; 78: 330-336.
7. Howie VK, Forbes GI. Scottish Respiratory Tuberculosis Survey. Edinburgh: Information and Statistics Division Publications, 1990.
8. Leitch AG, Rubilar M, Curnow J et al. Scottish national survey of tuberculosis notifications in 1993 with special reference to the prevalence of HIV seropositivity. Thorax 1996; 51: 78-81.
9. The British Thoracic Society Research Committee and the Medical Research Council Cardiothoracic Epidemiology Group. The management of pulmonary tuberculosis in adults notified in England and Wales in 1988. Respir Med 1991; 85: 319-323.
10. Ormerod LP, Bentley C. The management of pulmonary TB in England and Wales in 1993. Thorax 51 (Suppl. 3): A31.
11. Pfaller MA. Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria. Am J Clin Pathol 1994; 101: 329-337.
12. Yew WW, Chau CH. Drug-resistant tuberculosis in the 1990s. Eur Respir J 1995; 8: 1184-1192.